Biosimilar Patent Dance, Or Musical Chairs? Amgen Says Sandoz Can't Stop Music
This article was originally published in The Pink Sheet Daily
Executive Summary
Sandoz dropped out of patent dance after obtaining Neulasta patent list and demanded Amgen immediately file infringement suit; Amgen instead filed complaint challenging Sandoz's maneuver.